|
Maryland Graft Vs Host Disease Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven medical advice, travels to or treatment by using a real medical. We are not doctors. Always consult your local Maryland Graft Vs Host Disease dr. about conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Maryland Graft Vs Host Disease Clinical research trials and Maryland Graft Vs Host Disease medical trials happen in hundreds of Maryland localities. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new drugs. The aim of the studies / undertakings is to solve certain human health questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to locate cures for all forms of circumstances. Maryland Graft Vs Host Disease Clinical Trials and other clinical trials allow for volunteers to have healthcare treatment choices before they are available to the general public. Many times the human subjects recieve treatment for free, and occasionally they are compensated for their time. Occasionally there is a cost for a Maryland Graft Vs Host Disease clinical trial. Human subjects typically obtain the finest healthcare available for their condition. Hazards are a reality, nonetheless, and may include more or frequent mD calls, medical hazards (possibly life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > Maryland Clinical Trials > Maryland Graft Vs Host Disease Clinical Trials
Maryland Graft Vs Host Disease Clinical Trials
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Research Network
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis
Condition: national_institute_of_dental_and_craniofacial_research_nidcr_clinical_trials.html
National Institute of Dental and Craniofacial Research (NIDCR)
Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Potential of Transplanted Stem Cells to Mature into Salivary Gland and Cheek Cells
Condition: national_institute_of_dental_and_craniofacial_research_nidcr_clinical_trials.html
National Institute of Dental and Craniofacial Research (NIDCR)
Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Stem Cell Transplant for Malignant Melanoma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
The Role of Cyclosporin in Blood Cell Transplants with T-Cell Add-Back for Blood Cancers
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Maryland Graft Vs Host Disease Clinical Trials
|
|
|
|
|
|
|
|
